Displaying drugs 26 - 50 of 153 in total
PF-05089771
PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).
Investigational
Matched Name: … PF-05089771 …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …
PF-06751979
PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Name: … PF-06751979 …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …
PF-06882961
PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Name: … PF-06882961 …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …
PF-04447943
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Name: … PF-04447943 …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
PF-04856884
PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma).
Investigational
Matched Name: … PF-04856884 …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …
PF-03882845
PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
Investigational
Matched Name: … PF-03882845 …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …
PF-04958242
PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.
Investigational
Matched Name: … PF-04958242 …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
PF-00610355
PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Investigational
Matched Name: … PF-00610355 …
Matched Description: … PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease …
Matched Description: … PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease …
PF-04691502
PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
Investigational
Matched Name: … PF-04691502 …
Matched Description: … PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast …
Matched Description: … PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast …
PF-03635659
Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Name: … PF-03635659 …
Matched Description: … Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
Matched Description: … Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
PF-05241328
PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity).
Investigational
Matched Name: … PF-05241328 …
Matched Description: … PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics ( …
Matched Description: … PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics ( …
PF-232798
PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Investigational
Matched Synonyms: … PF-00232798 …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …
PF-07304814
PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro), which is used by viruses like SARS-CoV-2 to assemble and multiply . Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its anti-viral effects . PF-07304814, developed by Pfizer, was first identified during the...
Investigational
Matched Name: … PF-07304814 …
Matched Description: … PF-07304814, developed by Pfizer, was first identified during the SARS outbreak in 2002-2003; it was ... PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro) ... Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its …
Matched Description: … PF-07304814, developed by Pfizer, was first identified during the SARS outbreak in 2002-2003; it was ... PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro) ... Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its …
PF-04457845
PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Investigational
Matched Name: … PF-04457845 …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
PF-06305591
Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).
Investigational
Matched Name: … PF-06305591 …
Matched Description: … Doses of PF-06305591). ... Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple …
Matched Description: … Doses of PF-06305591). ... Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple …
PF-05180999
PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
Investigational
Matched Name: … PF-05180999 …
Matched Description: … of a Modified-Release Formulation of PF-05180999). ... PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability …
Matched Description: … of a Modified-Release Formulation of PF-05180999). ... PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability …
PF-06291874
PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Name: … PF-06291874 …
Matched Description: … PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics ... And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus …
Matched Description: … PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics ... And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus …
PF-06260414
PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects).
Investigational
Matched Name: … PF-06260414 …
Matched Description: … PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability ... Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects …
Matched Description: … PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability ... Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects …
PF-05230907
PF-05230907 is a recombinant activated Factor X variant.
Investigational
Matched Name: … PF-05230907 …
Matched Description: … PF-05230907 is a recombinant activated Factor X variant. …
Matched Description: … PF-05230907 is a recombinant activated Factor X variant. …
PF-4191834
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Matched Name: … PF-4191834 …
Matched Description: … PF-4191834 has been investigated for the basic science of Asthma. …
Matched Description: … PF-4191834 has been investigated for the basic science of Asthma. …
PF-04991532
PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Glucose Metabolism Disorders.
Investigational
Matched Name: … PF-04991532 …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
PF-03463275
PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
Investigational
Matched Name: … PF-03463275 …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
PF-05175157
PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among others.
Investigational
Matched Name: … PF-05175157 …
Matched Description: … PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes …
Matched Description: … PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes …
PF-03654746
PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Investigational
Matched Name: … PF-03654746 …
Matched Description: … PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome …
Matched Description: … PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome …
PF-06273340
Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).
Investigational
Matched Name: … PF-06273340 …
Matched Description: … Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration ... and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of …
Matched Description: … Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration ... and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of …
Displaying drugs 26 - 50 of 153 in total